C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 261/04 (2006.01) A61K 31/42 (2006.01) A61K 31/454 (2006.01) A61P 7/02 (2006.01) C07D 261/08 (2006.01) C07D 413/06 (2006.01) C07D 413/10 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/10 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 491/04 (2006.01) C07D 491/10 (2006.01)
Patent
CA 2345210
This invention relates to novel isoxazolines and isoxazoles of formula (I) or a pharmaceutically acceptable salt or prodrug form thereof. The invention relates to novel isoxazolines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
L'invention concerne de nouveaux isoxazolines et isoxazoles correspondant à la formule (I) ou un sel pharmaceutiquement acceptable ou une forme de promédicament de ces composés. L'invention a pour objet de nouveaux isoxazolines qui peuvent servir d'antagonistes du complexe récepteur de fibrinogène IIb/IIIa glycoprotéines plaquettaires, des compositions pharmaceutiques contenant ces composés, des procédés pour préparer ces composés, isolément ou en combinaison avec d'autres agents thérapeutiques, qui sont utilisés pour inhiber l'agrégation plaquettaire, comme thrombolytiques et/ou dans le traitement de troubles thrombolytiques.
Judhav Prabhakar Kondaji
Smallheer Joanne M.
Wang Shuaige
Bristol-Myers Squibb Pharma Company
Dimock Stratton Clarizio Llp
Dupont Pharmaceuticals Company
LandOfFree
Novel isoxazoline fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel isoxazoline fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel isoxazoline fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1679139